DURECT Corporation Presenting at the Sixth Annual Needham Biotechnology and Medical Technology Conference
CUPERTINO, CA-
June 11, 2007
DURECT Corporation (Nasdaq: DRRX) announced today that it will present at the Sixth Annual Biotechnology and Medical Technology Conference being held at the New York Palace Hotel in New York City. Matthew J. Hogan, Chief Financial Officer, will be presenting at the conference on June 14, 2007 at 2:30 p.m. Eastern Time.
A live audio webcast of the presentation will be available by accessing DURECT’s homepage at www.durect.com and clicking “Investor Relations.” If you are unable to participate during the live webcast, the call will be archived on DURECT’s website under Audio Archive in the “Investor Relations” section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit www.durect.com.
SOURCE: DURECT Corporation
CONTACT: Matthew J. Hogan, Chief Financial Officer,
(408) 777-4936
Media Contact:
Feinstein Kean Healthcare
Jeremiah Hall, Senior Vice President,
+415 677-2700
jeremiah.hall@fkhealth.com
|
